Healthcare tech start-up, Occuity has secured £2.8m crowdfunding through crowdfunding platform Seedrs. The company, which describes itself as “diagnostic visionaries and pioneers of technological solutions that alleviate some of Humanity’s greatest healthcare challenges” will use the money for its new optical screening and monitoring devices.

Dr. Dan Daly, CEO and Co-founder of Occuity said: “We’re delighted to have become the largest ever MedTech raise on Seedrs and that our vision has resonated with so many people."

Senior Associate Sophie Payne and Solicitor Rachael Brenchley comprised the team from Boyes Turner law firm to provide legal support on the funding deal, which was completed in December.

“The team at Boyes Turner have provided valuable knowledge and support from the start and we look forward to continuing to work with them as we develop our technology and bring our first product to market later this year.” Dr. Daly added.

The optical screening devices that Occuity are focusing on as a result of the cash boost are designed to scan the human eye to detect the early signs of chronic health conditions such as diabetes.

Sophie Payne, Senior Associate from Boyes Turner’s corporate team said: “Crowdfunding is becoming an increasingly popular way for start-ups to raise funds and Occuity has shown how successful it can be. We are excited to see Occuity’s next chapter as they use this funding to develop their optical screening and monitoring devices.”

Occuity’s initial target of £1.8m was reached within 24 hours of its public launch.

Contact us


Tel: +44 (0)1424 777745

Fax: +44 (0)1424 777746



Kirkham Young Ltd.
The Old Court House
North Trade Road
East Sussex
TN33 0EX